Previous
Previous

2017.03.03. Psoriasis treatment efficacy of an Oral INV-17 ROR gamma inhibitor in a mouse Imiquimod Psoriasis model presented at the 2017 AAD Annual Meeting in Orlando, FL

Next
Next

2014.11.05. Superior treatment efficacy of novel oral DMARDs: INV-17 ROR gamma & INV-88 MIF inhibitors in murine CIA to be presented at the 2014 ACR Annual Meeting in Boston